IPF Clinical Trials

36 clinical trials for IPF across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• P4O2 ILD Extension — RECRUITING
• A Phase Ia Clinical Trial of HW241045 — RECRUITING · PHASE1
• Telerehabilitation in Patients With Idiopathic Pulmonary Fibrosis — RECRUITING · NA
• SB17170 Phase 2 Trial in IPF Patients — RECRUITING · PHASE2
• Turkish Validity and Reliability of SGRQ-I — RECRUITING
• The Role of Laryngopharyngeal Reflux in IPF — RECRUITING
• Sleep Hygiene, Sarcopenia, and Cognitive Function in Respiratory Disease — RECRUITING
• Phase I Study to Assess Safety, Tolerability, PK and PD of AGMB-447 in Healthy Participants and Participants With IPF — COMPLETED · PHASE1
• A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of RC010 Inhalation Powder in Healthy Participants — NOT_YET_RECRUITING · PHASE1
• A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis — NOT_YET_RECRUITING · PHASE3
• A PhaseⅠ Study of HW252001 in Healthy Subjects — NOT_YET_RECRUITING · PHASE1
• Application of Personalized Palliative Care in Patients With Newly Diagnosed Idiopathic Pulmonary Fibrosis — COMPLETED
• Safety, Tolerability, and Efficacy of MN-001 (Tipelukast) in Patients With Idiopathic Pulmonary Fibrosis — COMPLETED · PHASE2
• Diarrheal Adverse Events in Caucasian Patients With Idiopathic Pulmonary Fibrosis Undergoing Treatment With Nintedanib — ACTIVE_NOT_RECRUITING
• A Multiple Ascending Doses (MAD) Study of PMG1015 in Idiopathic Pulmonary Fibrosis Subjects — COMPLETED · PHASE1
• Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF — COMPLETED · PHASE2
• A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation Phase I Clinical Study to Assess the Safety, Pharmacokinetics, and Immunogenicity of HLX6018 in Healthy Subjects — COMPLETED · PHASE1
• Prognostic Score Comparison in IPF and HP — COMPLETED
• Assessment of Self-Care in Patients With Idiopathic Pulmonary Fibrosis (IPF) — ACTIVE_NOT_RECRUITING
• The Effectiveness of Pulmonary Rehabilitation on Saturation in Patients With Idiopathic Pulmonary Fibrosis — COMPLETED · NA
• Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis (COSMIC-IPF) — ACTIVE_NOT_RECRUITING · PHASE2
• A Study of Patients With Chronic Disease — TERMINATED
• Advancing Prevention of Pulmonary Fibrosis — ACTIVE_NOT_RECRUITING
• Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis — ACTIVE_NOT_RECRUITING · PHASE2
• A Study to Evaluate the Safety, Tolerability, PK and PD of HNC1058 — COMPLETED · PHASE1
• Effects of Home-based Inspiratory Muscle Training in Patients With IPF — COMPLETED · NA
• A Phase 2 Study to Evaluate Safety and Efficacy of AMB-05X in Subjects With Idiopathic Pulmonary Fibrosis — WITHDRAWN · PHASE2
• Functional MR Lung Imaging Using Hyperpolarised 129Xe — COMPLETED
• ILAs in CT Lung Cancer Screening Population — COMPLETED
• A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF — TERMINATED · PHASE2
• Inhaled NO in IPF and COPD During 6 Minute Walk Test — OTHER · PHASE2
• Idiopathic Pulmonary Fibrosis Job Exposures Study — COMPLETED
• Combined PEX, Rituximab and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations — COMPLETED · PHASE1
• Prospective Evaluation of Biomarker Profiles in Idiopathic Pulmonary Fibrosis — COMPLETED
• Nasal, Tracheal and Bronchial Mucosal Lining Fluid(MLF) Sampling From Patients With Respiratory Diseases — OTHER
• The Coagulation Cascade in Idiopathic Pulmonary Fibrosis — OTHER · NA

Refine this search